Mounjaro priced from Rs 14,000 for weekly administration. • Offers six dose strengths for personalized treatment. • Targets type 2 diabetes and obesity manageme
Author: PharmaSignal News Desk
Lupin partners with Sandoz for biosimilar ranibizumab commercialization. • Sandoz handles commercialization in multiple regions, excluding Germany. • Lupin will
Roche’s Atezolizumab injection (Tecentriq) approved for subcutaneous use in India. • Approval requires Roche to conduct a Phase IV clinical trial. • Subcutaneou
FDA launches a program to streamline the construction of drug manufacturing sites in the U.S., enhancing domestic production capabilities.